US 12331107
Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12331107 (Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody) held by AVALO THERAPEUTICS, INC. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AVALO THERAPEUTICS, INC.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/706, A61K39/3955